Moderna begins the procedures to market its Covid vaccine in Europe

Moderna prepares for the "commercial launch" of its vaccine

Moderna prepares for the “commercial launch” of its vaccine.

Modern biotechnology begins the procedures to request the authorization of its experimental vaccine against Covid-19, one of the most advanced in the world. The biotech company reported this Wednesday that it has received from the European Medicines Agency (EMA) confirmation that its candidate is eligible to submit a marketing authorization application in the European Union.

Moderna’s candidate is one of 10 currently in phase III clinical studies, the last stage before its commercialization in which its safety and efficacy are tested. The request for authorization by the biotech will include updated clinical information on its mRNA-1273 product, according to the company.

The approval of Moderna’s vaccine would mean that a large part of the production would come from Spain, since it signed a manufacturing agreement with Laboratorios Rovi to fill the vaccine in Madrid, in addition to other agreements in Europe with the Swiss company Lonza.

The EMA has already announced in recent days that it has started a process of continuous evaluation of the Pfizer and AstraZeneca vaccines, the two most advanced in the race to get approval in the European Union.

Pfizer's vaccine will be available in UK next week

Pfizer's vaccine will be available in UK next week The UK has become the first Western country to approve a Read more

Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective

Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective Moderna Inc said it will request authorization for emergency use in Read more

Pfizer's coronavirus vaccine sparks optimism

Pfizer's coronavirus vaccine sparks optimism. The European Commission announced this Wednesday an agreement reached with the pharmaceutical firms Pfizer and Read more

Pfizer’s late-stage coronavirus vaccine trial is near complete

Pfizer’s late-stage coronavirus vaccine trial is near complete. The countdown to the arrival of the Covid vaccine has begun. Pfizer Read more

45 vaccine candidates in human trials

45 vaccine candidates in human trials. Governments, companies, health systems and citizens scrutinize with great interest to know when a Read more

Moderna claims its COVID-19 vaccine produces a "robust" immune response

Moderna claims its COVID-19 vaccine produces a "robust" immune response. Scientists around the world will continue to search for a Read more

US Quickly Seeks COVID-19 Vaccine

US Quickly Seeks COVID-19 Vaccine. "Phase 1 of the clinical trial to evaluate an investigational vaccine designed for coronavirus disease Read more

Moderna lab, the small biotechnology that can save the world from COVID-19

Moderna lab, the small biotechnology that can save the world from COVID-19. Moderna is using a new technology: instead of Read more

Merger between Sanofi and Principia Biopharma

Merger between Sanofi and Principia Biopharma. The French pharmaceutical Sanofi has reached a "definitive agreement" to acquire the US laboratory Read more

CytoDyn rejected by the FDA

CytoDyn rejected by the FDA. The FDA rejected CytoDyn’s application for its lead program, an antibody to treat HIV in Read more

Leave a Reply